This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Otsuka Pharmaceutical Company, Limited, Somalogic, Incorporated. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 846 
1 out of 75 
Years Active: 2015
Title: Yuichi Ishikawa: Innovator in IL-6 Targeting Aptamers
Introduction
Yuichi Ishikawa is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of aptamers that target interleukin-6 (IL-6). His work has implications for treating and diagnosing conditions mediated by IL-6.
Latest Patents
Ishikawa holds a patent for "Aptamers that bind to IL-6 and their use in treating or diagnosing IL-6 mediated conditions." This patent provides pharmaceutical compositions comprising IL-6 aptamers, as well as methods for treating conditions using these aptamers. His innovative approach offers new avenues for therapeutic interventions.
Career Highlights
Throughout his career, Yuichi Ishikawa has worked with prominent companies in the pharmaceutical industry. He has been associated with Somalogic, Incorporated and Otsuka Pharmaceutical Company, Limited. His experience in these organizations has contributed to his expertise in the development of biopharmaceuticals.
Collaborations
Ishikawa has collaborated with esteemed colleagues, including Shashi Gupta and Masao Hirota. These partnerships have enhanced his research and development efforts in the field of aptamer technology.
Conclusion
Yuichi Ishikawa's contributions to the development of IL-6 targeting aptamers represent a significant advancement in biotechnology. His innovative work continues to pave the way for new therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile